Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...
How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...
The Autopian on MSN
Animated Cylon-like taillights are here so let's come up with some reasonable rules for using them
I think it’s pretty clear that we are currently living in an age of explosive taillight-related creativity and exploration. Taillight-focused clubs, bars, gyms, and bathhouses have never been more ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results